Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 1,921–1,940 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass I

Secret, Dry Spray, Aluminum chlorohydrate 23.5%, Antiperspirant, Lavender, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-383-10, UPC: 0 37000 72986 0

by The Procter & Gamble Company

Reason
Chemical contamination: presence of benzene
Recall initiated
November 23, 2021
Reported by FDA
January 24, 2024
Distribution
Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana

View recall →

Drug Recall Terminated Historical recordClass I

Secret, powder fresh, Aluminum chlorohydrate 24%, Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g), NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 each can Net Wt. 6OZ (170g), NDC: 37000-134-01, UPC 0 37000 58690 6; Distr. by: Procter & Gamble, Cincinnati, OH 45202

by The Procter & Gamble Company

Reason
Chemical contamination: presence of benzene
Recall initiated
November 23, 2021
Reported by FDA
January 24, 2024
Distribution
Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana

View recall →

Drug Recall Ongoing Historical recordClass I

4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).

by Pfizer Inc.

Reason
Presence of Particulate Matter; identified as glass
Recall initiated
December 21, 2023
Reported by FDA
January 24, 2024
Distribution
Nationwide in the USA and Puerto Rico.

View recall →

Drug Recall Ongoing Historical recordClass II

Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Grape Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-311-10.

by Pharma Nobis LLC

Reason
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
Recall initiated
December 21, 2023
Reported by FDA
January 24, 2024
Distribution
Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

Good Neighbor Pharmacy, DYE FREE, SUGAR FREE Magnesium Citrate Saline Laxative, Oral Solution, Cherry Flavor 10 fl. oz, Distributed by AmerisourceBergen, 1 West First Ave, Conshochoken, PA 19428, NDC 46122-741-38

by Pharma Nobis LLC

Reason
MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
Recall initiated
December 21, 2023
Reported by FDA
January 24, 2024
Distribution
Nationwide.

View recall →

Drug Recall Completed Historical recordClass II

Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam - 532 409 INDIA, NDC 55111-180-15

by Dr. Reddy's Laboratories, Inc.

Reason
Presence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.
Recall initiated
January 2, 2024
Reported by FDA
January 17, 2024
Distribution
USA Nationwide

View recall →

Drug Recall Ongoing Historical recordClass II

buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03

by Rising Pharma Holding, Inc.

Reason
Presence of Foreign Tablets/Capsules
Recall initiated
December 29, 2023
Reported by FDA
January 17, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.

by Lupin Pharmaceuticals Inc.

Reason
CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.
Recall initiated
December 20, 2023
Reported by FDA
January 17, 2024
Distribution
Product was distributed nationwide.

View recall →

Drug Recall Completed Historical recordClass I

Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53

by InvaGen Pharmaceuticals, Inc.

Reason
Defective Container: powder may leak out of the pouch
Recall initiated
November 17, 2023
Reported by FDA
January 17, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01

by Dr. Reddy's Laboratories, Inc.

Reason
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
Recall initiated
December 15, 2023
Reported by FDA
January 17, 2024
Distribution
US Nationwide.

View recall →

Drug Recall Ongoing Historical recordClass II

DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in 6000mL bags, Rx only, Fresenius Medical Care NA Waltham, MA 02451, NDC 49230-206-62.

by Fresenius Medical Care Holdings, Inc.

Reason
Lack of Sterility Assurance
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
Nationwide within the United States

View recall →

Drug Recall Ongoing Historical recordClass II

Quality Choice No Drip Severe Congestion Nasal Pump Mist, Oxymetazoline hydrochloride 0.05%, Nasal Decongestant, 12 Hours, 1 fl. oz. bottle, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd., Novi, MI 48375, NDC 63868-608-01, UPC 6-35515-98846-0

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Ongoing Historical recordClass II

Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%, 12 Hour Nasal Decongestant, 1 fl oz (30 mL) bottle, Distributed by C.D.M.A, Inc. 43157 W 9 Mile Rd. Novi, MI 48375, NDC# 63868-676-01, UPC 6-35515-98847-7.

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Ongoing Historical recordClass II

Premier Value Tussin Cough DM, Dextromethorphan HBr...Cough Suppressant, Guaifenesin...Expectorant, Alcohol Free, 8 FL OZ (237 mL) bottle, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne PA 19087, UPC 8-40986-03789-4.

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Ongoing Historical recordClass II

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.

by Seaway Pharma Inc.

Reason
CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.
Recall initiated
December 28, 2023
Reported by FDA
January 10, 2024
Distribution
MI, PA

View recall →

Drug Recall Terminated Historical recordClass III

Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1

by Azurity Pharmaceuticals, Inc.

Reason
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
Recall initiated
December 8, 2023
Reported by FDA
January 10, 2024
Distribution
USA nationwide.

View recall →

Drug Recall Ongoing Historical recordClass I

Sure Regular Antiperspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5518-06

by TCP HRB ACQUISITON LLC

Reason
Chemical contamination: Presence of benzene
Recall initiated
February 16, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide in the US and Canada

View recall →

Drug Recall Ongoing Historical recordClass I

Sure Unscented Anti-perspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5517-06

by TCP HRB ACQUISITON LLC

Reason
Chemical contamination: Presence of benzene
Recall initiated
February 16, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide in the US and Canada

View recall →

Drug Recall Ongoing Historical recordClass I

Brut Classic Antiperspirant & Deodorant (aluminum chlorohydrate 20.9%) packaged in a) 4 oz. (113g) aerosol cans (UPC 00827755070085, NDC 41595-7103-1) and b) 6 oz. (170g) aerosol cans (UPC 00827755070108, NDC 41595-7103-2), Distributed by Idelle Labs, Ltd. El Paso, TX 79912 USA

by TCP HRB ACQUISITON LLC

Reason
Chemical contamination: Presence of benzene
Recall initiated
February 16, 2022
Reported by FDA
January 3, 2024
Distribution
Nationwide in the US and Canada

View recall →

Drug Recall Ongoing Historical recordClass I

Magnum XXL 9800, 2000 mg per capsule, 1 capsule per blister pack, Distributed by Magnum Los Angelas CA. UPC 6 45759 99300 7. Amazon's ASIN# B07P7ZH797, B07P94J3ZT, B07P6VK6N3, B076HNPZZZ

by Meta Herbal

Reason
Marketed without an approved NDA/ANDA: Magnum XXL found to contain undeclared active pharmaceutical ingredient (API) - Sildenafil.
Recall initiated
November 29, 2023
Reported by FDA
January 3, 2024
Distribution
Nationwide in the USA. Product was sold via Amazon's Marketplace.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.